Polymorphisms of beta defensins are associated with the risk of severe acute pancreatitis

Pancreatology

Volumn 10, Issue 4, 2010, Pages 483-490

  Tiszlavicz, Z ^a   Szabolcs, A ^b   Takacs T ^b   Farkas, G ^b   Kovacs Nagy R ^c   Szantai E ^c   Sasvari Szekely M ^c   Mandi Y ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

^b UNIVERSITY OF SZEGED   (Hungary)

^c SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Acute pancreatitis; Copy number polymorphism; DEFB1; DEFB4; Severe acute pancreatitis; Single nucleotide polymorphisms; Defensins

Indexed keywords

BETA DEFENSIN; BETA DEFENSIN 1; BETA DEFENSIN 4;

5' UNTRANSLATED REGION; ACUTE PANCREATITIS; ADULT; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENE DOSAGE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 77955611178     PISSN: 14243903     EISSN: 14243911     Source Type: Journal    
DOI: 10.1159/000276987     Document Type: Article

References (33)

1. Beger HG, Bittner R, Block S, Büchler M: Bacterial contamination of pancreatic necrosis. A prospective clinical study. Gastroenterology 1986; 81: 433-438.
2. Juvonen PO, Alhava EM, Takala JA: Gut permeability in patients with acute pancreatitis. Scand J Gastroenterol 2000; 35: 1314-1318.
3. Ammori BJ, Leeder PC, King RF, Barclay GR, Martin IG, Larvin M, McMahon MJ: Early increase in intestinal permeability in patients with severe acute pancreatitis: correlation with endotoxemia, organ failure, and mortality. J Gastrointest Surg 1999; 3: 252-262.
4. Yasuda T, Takeyama Y, Ueda T, Shinzeki M, Sawa H, Nakajima T, Kuroda Y: Breakdown of intestinal mucosa via accelerated apopto-sis increases intestinal permeability in experimental severe acute pancreatitis. J Surg Res 2006;135: 18-26.
5. Masamune A, Kikuta K, Watanabe T, Satoh K, Satoh A, Shimosegawa T: Pancreatic stellate cells express Toll-like receptors. J Gastroenterol 2008; 43: 352-362.
6. Müller CA, Autenrieth IB, Peschel A: Innate defenses of the intestinal epithelial barrier. Cell Mol Life Sci 2005; 62: 1297-1307.
7. Ganz T: Defensins: antimicrobial peptides of innate immunity. Nat Rev Immunol 2003; 3: 710-720. (Pubitemid 41070812)
8. Schneider JJ, Unholzer A, Schaller M, Schäfer-Korting M, Korting HC: Human defensins. J Mol Med 2005; 83: 587-595.
9. Schutte BC, Mitros JP, Bartlett JA, Walters JD, Jia HP, Welsh MJ, Casavant TL, McCray PB Jr: Discovery of five conserved beta-de-fensin gene clusters using a computational search strategy. Proc Natl Acad Sci USA 2002; 99: 2129-2133.
10. Schnapp D, Reid CJ, Harris A: Localization of expression of human beta defensin-1 in the pancreas and kidney. J Pathol 1998; 186: 99-103.
11. Zhao C, Wang I, Lehrer RI: Widespread expression of beta-defensin hBD-1 in human secretory glands and epithelial cells. FEBS Lett 1996; 396: 319-322.
12. Dork T, Stuhrmann M: Polymorphisms of the human beta-defensin-1 gene. Mol Cell Probes 1998; 12: 171-173.
13. Den Dunnen JT, Antonarakis SE: Mutation nomenclature extensions and suggestions to describe complex mutations: a discussion. Hum Mutat 2000; 15: 7-12.
14. Sun CQ, Arnold R, Fernandez-Golarz C, Parrish AB, Almekinder T, He J, Ho SM, Svo-boda P, Pohl J, Marshall FF, Petros JA: Human beta-defensin-1, a potential chromosome 8p tumor suppressor: control of transcription and induction of apoptosis in renal cell carcinoma. Cancer Res 2006; 66: 8542-8549.
15. Tesse R, Cardinale F, Santostasi T, Polizzi A, Manca A, Mappa L, Iacoviello, De Robertis F, Logrillo VP, Armenio L: Association of |3-defensin-1 gene polymorphisms with Pseu-domonas aeruginosa airway colonization in cystic fibrosis. Genes Immun 2008; 9: 57-60.
16. Levy H, Raby BA, Lake S, Tantisira KG, Kwi-atkowski D, Lazarus R, Silverman EK, Rich-ter B, Klimecki WT, Vercelli D, Martinez FD, Weiss ST: Association of defensin beta I gene polymorphisms with asthma. J Allergy Clin Immunol 2005; 115: 252-258. (Pubitemid 40215086)
17. Matsushita I, Hasegawa K, Nakata K, Yasu-da, K, Tokunaga K, Keicho N: Genetic variants of human beta-defensin-I and chronic obstructive pulmonary disease. Biochem Biophys Res Commun 2002; 29: 17-22.
18. Kocsis ÁK, Lakatos PL, Somogyvári F, Fuszek P, Papp J, Fischer S, Szamosi T, Lakatos L, Hofner P, Mándi Y: Association of beta-defensin 1 nucleotide polymorphisms with Crohn's disease. Scand J Gastroenterol 2007; 17: 1-9.
19. Hollox EJ, Armour JA, Barber JC: Extensive normal copy number variation of a beta-defensin antimicrobial-gene cluster. Am J Hum Genet 2003; 73: 591-600.
20. Linzmeier RM, Ganz T: Human defensin gene copy number polymorphisms: comprehensive analysis of independent variation in ct-and fi-defensin regions at 8p22-p23. Genomics 2005; 86: 423-430.
21. Sargen K, Demaine AG, Kingsnorth AN: Cytokine gene polymorphisms in acute pancreatitis. JOP 2000; 1: 24-35.
22. Hofner P, Balog A, Gyulai Z, Farkas G, Ra-konczay Z, Takács T: Polymorphism on the IL-8 gene, but not in the TLR4 gene, increases the severity of acute pancreatitis. Pancre-atology 2006; 6: 542-548.
23. Ranson JH: Etiological and prognostic factors in human acute pancreatitis: a review. Am J Gastroenterol 1982; 77: 633-638.
24. Wallace AM, He J-Q, Burkett KM, Ruan J, Connett JE, Anthonisen NR, Paré PD, Sand-ford AJ: Contribution of alpha-and beta-de-fensins to lung function decline and infection in smokers: an association study. Respir Res 2006; 7: 76-80.
25. Szilagyi A, Blasko B, Szilassy D, Fust G, Sas-vari-Szekely M, Ronai ZS: Real-time PCR quantification of human complement C4A and C4B genes. BMC Genet 2006; 7: 1.
26. Pezzilli R, Fantini L: Probiotics and severe acute pancreatitis. JOP 2006; 7: 92-93.
27. Olah A, Belagyi T, Issekutz A, Gamal ME, Bengmark S: Randomized clinical trial of specific lactobacillus and fibre supplement to early enteral nutrition in patients with acute pancreatitis. Br J Surg 2002; 89: 1103-1107.
28. Tromm A, Niewerth U, Khoury M, Baestlein E, Wilhelms G, Schulze J, Stolte M: The pro-biotic E. coli strain Nissle 1917 for the treatment of collagenous colitis: first results of an open-label trial. Z Gastroenterol 2004; 42: 365-369.
29. Rachmilewitz D, Katakura K, Karmeli F, Hayashi T, Reinus C, Rudensky B, Akira S, Takeda K, Lee J, Takabayashi K, Raz E: Tolllike receptor 9 signaling mediates the antiinflammatory effects of probiotics in murine experimental colitis. Gastroenterology 2004; 126: 520-528.
30. Prado-Montes de Oca E, Garcia-Vargas A, Lozano-Inocencio R, Gallegos-Arreola MP, Sandoval-Ramirez L, Davalos-Rodriguez NO, Figuera LE: Association of beta-defensin 1 single nucleotide polymorphisms with atopic dermatitis. Int Arch Allergy Immunol 2007; 142: 211-218.
31. Jurevic RJ, Bai M, Chadwick RB, White TC, Dale BA: Single-nucleotide polymorphisms (SNPs) in human fi-defensin 1: high-throughput SNP assays and association with Candida carriage in type I diabetics and nondiabetic controls. J Clin Microbiol 2003; 41: 90-96.
32. Braida L, Boniotto M, Pontillo A, Tovo PA, Amoroso A, Crovella S: A single-nucleotide polymorphism in the human beta-defensin 1 gene is associated with HIV-1 infection in Italian children. AIDS 2004; 18: 1598-1600.
33. Fellermann K, Stange DE, Schaeffeler E, Schmalzl H, Wehkamp J, Bevins CL, Rein-isch W, Teml A, Schwab M, Lichter P, Radl-wimmer B, Stange EF: A chromosome 8 gene-cluster polymorphism with low human beta-defensin 2 gene copy number predisposes to Crohn disease of the colon. Am J Hum Genet 2006; 79: 439-448.